Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Iopromide

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44339   clinical trials with a EudraCT protocol, of which   7369   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    5 result(s) found for: Iopromide. Displaying page 1 of 1.
    EudraCT Number: 2010-019740-39 Sponsor Protocol Number: COMEDIANS Start Date*: 2010-04-26
    Sponsor Name:ISTITUTI FISIOTERAPICI OSPITALIERI
    Full Title: Isotonic contrast (iodixanol) administration vs. low osmolar contrast (iopromide) use: evaluating risk of contrast-induced nephropathy in cancer patients at very low risk
    Medical condition: Oncological patients undergoing to diagnostic imaging
    Disease: Version SOC Term Classification Code Term Level
    9.1 10022893 HLGT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2013-002051-15 Sponsor Protocol Number: KM-HYPO Start Date*: 2014-11-04
    Sponsor Name:Innsbruck Medical University, Department of Radiology, Section of Microinvasive Therapy
    Full Title: Systemic hypotension following intravenous administration of contrast medium during computed tomography.
    Medical condition: Primary goal of this study is to quantify changes in systolic and diastolic blood pressure, heart rate and pO2 before and after i.v. administration of either IOCM or LOCM. In particular the occurre...
    Disease:
    Population Age: Elderly Gender: Male, Female
    Trial protocol: AT (Completed)
    Trial results: View results
    EudraCT Number: 2012-004742-16 Sponsor Protocol Number: FARM823BHC Start Date*: 2013-01-04
    Sponsor Name:AZIENDA OSPEDALIERO UNIVERSITARIA OSPEDALI RIUNITI UMBERTO I - G.M.LANCISI - G.SALESI
    Full Title: Evaluation of the risk of nephrotoxicity caused by the intravenous administration of nonionic iodinated contrast media
    Medical condition: The present study was designed to determine the incidence of serious complications with special reference to contrast induced nephropaty (CIN) in patients receiving iv iodinated contrast media (I...
    Disease:
    Population Age: Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2019-000326-22 Sponsor Protocol Number: IEO960 Start Date*: 2020-09-22
    Sponsor Name:ISTITUTO EUROPEO DI ONCOLOGIA
    Full Title: The role of Contrast-Enhanced Spectral Mammography (CESM) in the diagnostic process of breast cancer: can it improve specificity of first-line examinations and therefore reduce the suspicious lesio...
    Medical condition: Patients with breast lesions undergoing further examination
    Disease: Version SOC Term Classification Code Term Level
    20.0 10038604 - Reproductive system and breast disorders 10061021 Breast disorder PT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: IT (Trial now transitioned)
    Trial results: (No results available)
    EudraCT Number: 2010-021826-37 Sponsor Protocol Number: ISO-44-012 Start Date*: 2010-10-19
    Sponsor Name:GUERBET
    Full Title: Xenetix 350 : comparative assessment of image quality for coronary CT angiography
    Medical condition: Symptomatic patients suspected for coronary artery disease scheduled for a coronary CT angiography.
    Disease: Version SOC Term Classification Code Term Level
    12.1 10060808 Computerized tomogram coronary artery LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Completed) DE (Completed) IT (Completed) ES (Completed)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Thu May 29 01:49:49 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA